Research Bridge Partners' Seed Capital Investment in Asalyxa Bio Advances Dr. Lola Eniola-Adefeso's Immune Cell Targeted Therapeutic Platform

AUSTIN, Texas, March 9, 2021 /PRNewswire/ -- Research Bridge Partners -- a 501 (c) (3) organization that bridges preeminent innovators at mid-continent research universities with t…